Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors - PubMed (original) (raw)
. 2003 May 8;22(18):2812-22.
doi: 10.1038/sj.onc.1206388.
Affiliations
- PMID: 12743604
- DOI: 10.1038/sj.onc.1206388
Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors
Roberto Bianco et al. Oncogene. 2003.
Abstract
We have examined the possible mechanisms of resistance to the epidermal growth factor receptor (EGFR) inhibitors in tumor cells with variable levels of EGFR. ZD1839 (Iressa) is a small-molecular-weight, ATP-mimetic that specifically inhibits the EGFR tyrosine kinase. A431 cell growth was markedly inhibited by ZD1839 (IC(50)< or =0.1 microM) whereas the MDA-468 cells were relatively resistant (IC(50)2 microM). Low doses of ZD1839 delayed cell cycle progression and induced apoptosis in A431 cells but not in MDA-468 cells. In both cell lines, 0.1 microM ZD1839 eliminated EGFR phosphorylation. However, the basal activity of the phosphatidylinositol-3 kinase (PI3 K) target Akt was eliminated in A431 but not in MDA-468 cells, implying that their Akt activity is independent of EGFR signals. A431 cells express PTEN/MMAC1/TEP, a phosphatase that can dephosphorylate position D3 of phosphatidylinositol-3,4,5 trisphosphate, the site that recruits the plecstrin-homology domain of Akt to the cell membrane. On the contrary, MDA-468 cells lack the phosphatase and tensin homolog (PTEN), potentially setting Akt activity at a high threshold that is unresponsive to EGFR inhibition alone. Therefore, we reintroduced (PTEN) by retroviral infection in MDA-468 cells. In MDA-468/PTEN but not in vector controls, treatment with ZD1839 inhibited P-Akt levels, induced relocalization of the Forkhead factor FKHRL1 to the cell nucleus, and increased FKHRL1-dependent transcriptional activity. ZD1839 induced a greater degree of apoptosis and cell cycle delay in PTEN-reconstituted than in control cells. These data suggest that loss of PTEN, by permitting a high level of Akt activity independent of receptor tyrosine kinase inputs, can temporally dissociate the inhibition of the EGFR with that of Akt induced by EGFR inhibitors. Thus, in EGFR-expressing tumor cells with concomitant amplification(s) of PI3K-Akt signaling, combined blockade of the EGFR tyrosine kinase and Akt should be considered as a therapeutic approach.
Similar articles
- Pten signaling in gliomas.
Knobbe CB, Merlo A, Reifenberger G. Knobbe CB, et al. Neuro Oncol. 2002 Jul;4(3):196-211. Neuro Oncol. 2002. PMID: 12084351 Free PMC article. Review. - Studies with ZD1839 in preclinical models.
Sirotnak FM. Sirotnak FM. Semin Oncol. 2003 Feb;30(1 Suppl 1):12-20. doi: 10.1053/sonc.2003.50028. Semin Oncol. 2003. PMID: 12644980 Review.
Cited by
- The covert symphony: cellular and molecular accomplices in breast cancer metastasis.
Si H, Esquivel M, Mendoza Mendoza E, Roarty K. Si H, et al. Front Cell Dev Biol. 2023 Jun 27;11:1221784. doi: 10.3389/fcell.2023.1221784. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37440925 Free PMC article. Review. - Reviewing the Prospective Pharmacological Potential of Isothiocyanates in Fight against Female-Specific Cancers.
Shoaib S, Khan FB, Alsharif MA, Malik MS, Ahmed SA, Jamous YF, Uddin S, Tan CS, Ardianto C, Tufail S, Ming LC, Yusuf N, Islam N. Shoaib S, et al. Cancers (Basel). 2023 Apr 20;15(8):2390. doi: 10.3390/cancers15082390. Cancers (Basel). 2023. PMID: 37190316 Free PMC article. Review. - Report of multiple high-grade gliomas in two patients with shared retained ATRX, wild-type IDH, losses of CDKN2A genes and alterations in the PTEN-PI3K axis.
Khatchadourian C, Guo J, Prasad CJ, Orlando RA, Parsa C. Khatchadourian C, et al. J Surg Case Rep. 2023 Mar 30;2023(3):rjad139. doi: 10.1093/jscr/rjad139. eCollection 2023 Mar. J Surg Case Rep. 2023. PMID: 37008737 Free PMC article. - Brain type of creatine kinase induces doxorubicin resistance via TGF-β signaling in MDA-MB-231 breast cancer cells.
Son S, Yoo SA, Nam K, Oh S, Lee KM, Yi JY, Shin I. Son S, et al. Anim Cells Syst (Seoul). 2022 Aug 31;26(5):203-213. doi: 10.1080/19768354.2022.2107070. eCollection 2022. Anim Cells Syst (Seoul). 2022. PMID: 36275445 Free PMC article. - Epidermal Growth Factor Receptor Variant III Mutation, an Emerging Molecular Marker in Glioblastoma Multiforme Patients: A Single Institution Study on the Indian Population.
Garima G, Thanvi S, Singh A, Verma V. Garima G, et al. Cureus. 2022 Jun 29;14(6):e26412. doi: 10.7759/cureus.26412. eCollection 2022 Jun. Cureus. 2022. PMID: 35911278 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous